Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Oncotarget|July 14, 2020
Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarkingJoshua T Rose, Eliana Moskovitz, Joseph R Boyd, et al.
Journal of Biomolecular Techniques : JBT|July 15, 2022
The Shared Core Resource as a Partner in Innovative Scientific Research: Illustration from an Academic Microscopy Imaging CenterDouglas J Taatjes, Prachi N Ghule, Nicole A Bouffard, et al.
Nature Communications|December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancerSangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Blood|August 10, 2018
Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomasIrene Scarfò, Maria Ormhøj, Matthew J Frigault, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 6, 2026
Perivascular Diffusivity Suggests Dynamic and Modifiable Glymphatic Transit in Idiopathic Intracranial HypertensionMarc A Bouffard, Donnella S Comeau, Mahsa A Avanaki, et al.
Cancer Cell|April 22, 2022
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemiaMark B Leick, Harrison Silva, Irene Scarfò, et al.
Nature Communications|November 2, 2025
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical modelsFilippo Birocchi, Antonio J Almazan, Aiyana Parker, et al.
Blood Cancer Discovery|January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic MalignanciesStefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.
Pageof 13